Harmony Biosciences Announces Strategic Leadership Transition: Peter Anastasiou to Succeed Dr. Jeffrey M. Dayno as CEO on November 7, 2026 Posted by
Safety Scrutiny Intensifies: Novartis Reports New Tumor Cases Linked to Zolgensma on November 7, 2026 Posted by
The End of a Scientific Debate: AAV Gene Therapies and the Emerging Cancer Risk on November 7, 2026 Posted by
Executive Moves: Sarah Browne Joins MetaVia as Chief Medical Officer Amidst a Shifting Biopharma Landscape on November 7, 2026 Posted by
The Warming Night: How Climate Change is Eroding Our Global Sleep Health on November 7, 2026 Posted by
Harmony Biosciences Announces Strategic Leadership Transition: Peter Anastasiou to Succeed Dr. Jeffrey M. Dayno as CEO on November 7, 2026 Posted by
Safety Scrutiny Intensifies: Novartis Reports New Tumor Cases Linked to Zolgensma on November 7, 2026 Posted by
The End of a Scientific Debate: AAV Gene Therapies and the Emerging Cancer Risk on November 7, 2026 Posted by
Posted in Sleep Health Harmony Biosciences Announces Strategic Leadership Transition: Peter Anastasiou to Succeed Dr. Jeffrey M. Dayno as CEO on November 7, 2026
